Nosocomial transmission of hepatitis C virus in a Dutch dialysis centre;Nosocomiale transmissie van het hepatitis-C-virus in een Nederlands dialysecentrum

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 15, 1999, Pages 801-806

  Schneeberger, P M ^a,b   Doorenbos, C J ^a   Van Der Vliet, W ^a   Bergervoet, P ^a,c   Quint, W ^a   Van Doorn, L J ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

^c Afd Moleculaire Biologie   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTAMINATION; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; GENOTYPE; GLOVE; HEMODIALYSIS; HEPATITIS C; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; MAJOR CLINICAL STUDY; NETHERLANDS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; SERODIAGNOSIS; VIRUS TRANSMISSION;

CLUSTER ANALYSIS; CROSS INFECTION; DISEASE TRANSMISSION, HORIZONTAL; EQUIPMENT AND SUPPLIES; FEMALE; GENOTYPE; GLOVES, PROTECTIVE; HEMODIALYSIS UNITS, HOSPITAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INFECTION CONTROL; MALE; NETHERLANDS; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0033541679     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gonzalez A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muniz E, et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology 1995;22:439-45.
2. Horowitz B, Prince AM, Horowitz MS, Watklevicz C. Viral safety of solvent-detergent treated blood products. Dev Biol Stand 1993; 81:147-61.
3. Pereira BJ, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, et al. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992;327:910-5.
4. Neal KR, Jones DA, Killey D, James V. Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect 1994;112:595-601.
5. Zeuzem S, Teuber G, Lee JH, Ruster B, Roth WK. Risk factors for the transmission of hepatitis C. J Hepatol 1996;24(2 Suppl):3-10.
6. Hou CH, Chen WY, Kao JH, Chen DS, Yang Y, Chen JJ, et al. Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 1995;45:381-5.
7. Kao JH, Chen PJ, Yang PM, Lai MY, Sheu JC, Wang TH, et al. Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses. J Infect Dis 1992;166:900-3.
8. Irie Y, Hayashi H, Yokozeki K, Kashima T, Okuda K. Hepatitis C infection unrelated to blood transfusion in hemodialysis patients. J Hepatol 1994;20:557-9.
9. Schneeberger PM, Vos J, Dijk WC van. Prevalence of antibodies to hepatitis C virus in a Dutch group of haemodialysis patients related to risk factors. J Hosp Infect 1993;25:265-70.
10. Werkgroep Infectie Preventie. Infectiepreventie bij hemodialyse. Richtlijn nr 33. Leiden: Academisch Centrum; 1997.
11. Schneeberger PM, Keur I, Vliet W van der, Hoek K van, Boswijk H, Loon AM van, et al. Hepatitis C virus infection in dialysis centers in the Netherlands: a national survey by serological and molecular methods. J Clin Microbiol 1998;36:1711-5.
12. Poel CL van der, Reesink HW, Mauser-Bunschoten EP, Kaufmann RH, Leentvaar-Kuypers A, Chamuleau RA, et al. Prevalence of anti-HCV antibodies confirmed by recombinant immunoblot in different population subsets in the Netherlands. Vox Sang 1991:61:30-6.
13. Doom LJ van, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NSI of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995;69:773-8.
14. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994;43:415-9.
15. Peer Y van de, Wachter R de. TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft environment. Comput Appl Biosci 1994;10:569-70.
16. Jadoul M, Cornu C. Ypersele de Strihou C van. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. The UCL Collaborative Group. Kidney Int 1993;44:1322-6.
17. Stuyver L, Claeys H, Wyseur A, Arnhem W van. Beenhouwer H de, Uytendaele S. et al. Hepatitis C virus in a hemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 1996: 49;889-95.
18. Valderrahano F, Berthoux FC, Jones EHP. Mehls O. Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA registry. European Dialysis and Transplant Association-European Renal Association. Nephrol Dial Transplant 1996:11(Suppl 1):2-21.
19. Schneeberger P, Toonen N, Keur I, Hamersvelt HW van. Infection control of hepatitis C in Dutch dialysis centres. Nephrol Dial Transplant 1998;13:3037-40.
20. Bukh J, Wantzin P, Krogsgaard K, Knudsen F, Purcell RH, Miller RH. High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group. J Infect Dis 1993;168:1343-8.
21. Dore GJ, Kaldor JM, McCaughan GW, Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus. BMJ 1997;315:333-7.
22. Jadoul M. Transmission routes of HCV infection in dialysis. Nephrol Dial Transplant 1996;11(Suppl 4):36-8.
23. Tribl B, Oesterreicher C, Pohanka E, Sunder-Plassmann G, Petermann D, Muller C. GBV-C/HGV in hemodialysis patients: anti-E2 antibodies and GBV-C/HGV-RNA in serum and peripheral blood mononuclear cells. Kidney Int 1998;53:212-6.